HomeCompareNMFCL vs BTI

NMFCL vs BTI: Dividend Comparison 2026

NMFCL yields 12.89% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NMFCL wins by $16.0K in total portfolio value
10 years
NMFCL
NMFCL
● Live price
12.89%
Share price
$25.26
Annual div
$3.26
5Y div CAGR
3.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$53.7K
Annual income
$4,382.25
Full NMFCL calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — NMFCL vs BTI

📍 NMFCL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNMFCLBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NMFCL + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NMFCL pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NMFCL
Annual income on $10K today (after 15% tax)
$1,095.31/yr
After 10yr DRIP, annual income (after tax)
$3,724.91/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, NMFCL beats the other by $1,356.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NMFCL + BTI for your $10,000?

NMFCL: 50%BTI: 50%
100% BTI50/50100% NMFCL
Portfolio after 10yr
$45.7K
Annual income
$3,584.44/yr
Blended yield
7.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

NMFCL
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NMFCL buys
0
BTI buys
0
No recent congressional trades found for NMFCL or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNMFCLBTI
Forward yield12.89%5.38%
Annual dividend / share$3.26$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR3.1%11.3%
Portfolio after 10y$53.7K$37.7K
Annual income after 10y$4,382.25$2,786.64
Total dividends collected$26.5K$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NMFCL vs BTI ($10,000, DRIP)

YearNMFCL PortfolioNMFCL Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$12,029$1,328.55$11,299$598.92+$730.00NMFCL
2$14,410$1,539.80$12,794$703.91+$1.6KNMFCL
3$17,197$1,777.46$14,518$829.07+$2.7KNMFCL
4$20,444$2,043.82$16,513$978.64+$3.9KNMFCL
5$24,216$2,341.23$18,827$1,157.84+$5.4KNMFCL
6$28,584$2,672.15$21,518$1,373.12+$7.1KNMFCL
7$33,624$3,039.10$24,657$1,632.46+$9.0KNMFCL
8$39,422$3,444.65$28,329$1,945.74+$11.1KNMFCL
9$46,073$3,891.47$32,637$2,325.33+$13.4KNMFCL
10$53,680$4,382.25$37,708$2,786.64+$16.0KNMFCL

NMFCL vs BTI: Complete Analysis 2026

NMFCLStock

New Mountain Finance Corporation is a Business Development Company specializing in investments in middle market companies and debt securities at various levels of the capital structure, including first and second lien debt, unsecured notes, bonds, and mezzanine securities. It invests in various industries that include software, education, business services, distribution and logistics, federal services, healthcare services and products, healthcare facilities, energy, media, consumer and industrial services, healthcare Information Technology, Information Technology and services, specialty chemicals and materials, telecommunication, retail, and power generation. It seeks to invest in United States. It typically invests between $10 million and $50 million. Within middle market it seeks to invest in companies having EBITDA between $20 million and $200 million. It prefers to invest in equity interests, such as preferred stock, common stock, warrants, or options received in connection with its debt investments and directly in the equity of private companies. The fund makes investments through both primary originations and open-market secondary purchases. It invests primarily in debt securities that are rated below investment grade and have contractual unlevered returns of 10% to 15%. The firm may also invest in distressed debt and related opportunities and prefers to invest in targets having private equity sponsorship. It seeks to hold its investments between five years and ten years. The fund prefer to have majority stake in companies.

Full NMFCL Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this NMFCL vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NMFCL vs SCHDNMFCL vs JEPINMFCL vs ONMFCL vs KONMFCL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.